Ipsen SA (WBO:IPN)
€ 120.1 0.8 (0.67%) Market Cap: 10.07 Bil Enterprise Value: 9.85 Bil PE Ratio: 15.70 PB Ratio: 2.63 GF Score: 87/100

Ipsen SA M&A Call Transcript

Jan 09, 2023 / 02:00PM GMT
Release Date Price: €101.2
Operator

Hello, and welcome to the Ipsen conference call and webcast on acquisition of Albireo.

I now hand you over to David Loew, Ipsen's CEO. Please go ahead, sir.

David Loew
Ipsen S.A. - MD, CEO & Director

Thank you, operator. Good afternoon or good morning, everyone. As you just heard, I'm David Loew, Chief Executive of Ipsen. We're live at the JPMorgan Healthcare Conference in San Francisco, and I'm delighted that you have joined us today as we take you through today's exciting news on the acquisition of Albireo.

Please turn to Slide 2. This is our usual safe harbor statements which outlines the routine risks and uncertainties contained within this presentation.

Please turn to Slide 3. I'm joined today by Howard Mayer, Ipsen's Head of Research & Development; as well as our CFO, Aymeric Le Chatelier. We'll provide a brief presentation before using the majority of the time to answer your questions.

Please turn to Slide 4. I will begin the presentation by taking you through the strategic rationale for the acquisition. I

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot